Mahusay, Nathalia Kim C.
HRN: 18-25-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2026
CEFUROXIME 1.5GM (VIAL)
04/05/2026
04/12/2026
IV
510mg
Q8
UTI
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines